Deerfield Beach, FL -- (SBWIRE) -- 07/13/2015 -- About Statin

Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin.

Analysts forecast the global statin market to decline at a CAGR of 7.50% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global statin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of statins used for the management of lipid abnormalities and lipid-associated comorbidities such as stroke and coronary heart disease. This report provides a discussion of the market in the following three regions: Americas, APAC, and EMEA.

Global Statin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Visit Request For Report Sample Here:
http://www.marketresearchstore.com/report/global-statin-market-2015-2019-24070#requestSample

Key Regions
- Americas
- APAC
- EMEA

Key Vendors
- AstraZeneca
- Merck
- Novartis
- Pfizer

Other Prominent Vendors
- Amgen
- Aurobindo Pharma
- Abbvie
- Abbott
- Biocon
- BC World Pharm
- Cipla
- Concord Biotech
- CKD Bio
- CJ HealthCare Corporation
- Cerenis Therapeutics
- GlaxoSmithKline
- HanAll BioPharma
- JX Pharmaceuticals
- Kowa
- Lupin
- Livzon
- Mylan
- Merz Pharmaceuticals
- SUN Pharma
- Teva
- Torrent Pharmaceuticals
- Zydus Cadila

Market Driver
- Rising Number of High Cholesterol Cases
- For a full, detailed list, view our report

Market Challenge
- Lack of Novel Molecules in Statins Category
- For a full, detailed list, view our report

Market Trend
- Switch from Statins to Non-statins
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?